Belgian start-up working on ‘universal’ coronavirus vaccine - (The Brussels Times via NewsPoints Desk)

  • MyNEO is working on a universal coronavirus vaccine through machine-learning and cancer treatment technologies, as reported The Brussels Times on Wednesday.

  • The start-up said it had identified a promising peptide-based therapy capable of creating a targeted immune reaction against COVID-19 and other types of coronavirus.

  • "Normally, we compare DNA sequences of cancer cells with a patient's healthy, normal cells," the company noted, adding that "the various errors or mutations that appear in a tumour cause mutated proteins, which the patient’s immune system can recognise."

  • MyNEO said it had been able to identify essential molecular compounds of the SARS-CoV-2, paving the way for a potential vaccine.

  • "By specifically targeting fragments that are necessary for the virus' activity, the vaccine would have a better effect against both SARS-CoV-2 and all other future forms of the virus' family which share the same components," the company added.

  • "Our algorithms are able to predict which fragments of the mutated proteins are interesting for targeting a vaccine," said MyNEO, which is aiming to test the vaccine on humans in 2021.

To read more NewsPoints articles, click here.